ACE抑制剂-话题@MedSci

#ACE抑制剂#

11篇内容 | 668人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1587539, encodeId=8265158e5392e, content=<a href='/topic/show?id=d1201843d5' target=_blank style='color:#2F92EE;'>#ACE抑制剂#</a>, objectTitle=Hypertension：伴有白蛋白尿的高血压成人中使用ACE抑制剂或ARB的趋势, objectType=article, longId=203492, objectId=e99720349246, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e99720349246, replyNumber=0, likeNumber=39, createdTime=2020-11-18, rootId=0, userName=huanbaofeng, userId=fca217484051, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e99720349246, moduleTitle=Hypertension：伴有白蛋白尿的高血压成人中使用ACE抑制剂或ARB的趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e99720349246)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587538, encodeId=88ed158e538fe, content=<a href='/topic/show?id=d1201843d5' target=_blank style='color:#2F92EE;'>#ACE抑制剂#</a>, objectTitle=ACE抑制剂和血管紧张素受体阻滞剂（ARBs）可能增加罹患COVID-19的风险, objectType=article, longId=190727, objectId=788c190e27af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=788c190e27af, replyNumber=0, likeNumber=29, createdTime=2020-03-26, rootId=0, userName=huanbaofeng, userId=fca217484051, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=788c190e27af, moduleTitle=ACE抑制剂和血管紧张素受体阻滞剂（ARBs）可能增加罹患COVID-19的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=788c190e27af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587537, encodeId=90b2158e5373c, content=<a href='/topic/show?id=d1201843d5' target=_blank style='color:#2F92EE;'>#ACE抑制剂#</a>, objectTitle=阿尔茨海默症治疗再遇挫折：Eisai和Biogen终止了BACE抑制剂elenbecestat的研发, objectType=article, longId=179448, objectId=9f5b1e9448be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f5b1e9448be, replyNumber=0, likeNumber=21, createdTime=2019-09-16, rootId=0, userName=huanbaofeng, userId=fca217484051, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f5b1e9448be, moduleTitle=阿尔茨海默症治疗再遇挫折：Eisai和Biogen终止了BACE抑制剂elenbecestat的研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f5b1e9448be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587536, encodeId=ada6158e536e4, content=<a href='/topic/show?id=d1201843d5' target=_blank style='color:#2F92EE;'>#ACE抑制剂#</a>, objectTitle=又一个阿尔茨海默氏症的候选药宣布失败：安进、诺华放弃BACE抑制剂试验, objectType=article, longId=175370, objectId=81a41e537040, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81a41e537040, replyNumber=0, likeNumber=25, createdTime=2019-07-14, rootId=0, userName=huanbaofeng, userId=fca217484051, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81a41e537040, moduleTitle=又一个阿尔茨海默氏症的候选药宣布失败：安进、诺华放弃BACE抑制剂试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81a41e537040)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587535, encodeId=ec53158e535c9, content=<a href='/topic/show?id=d1201843d5' target=_blank style='color:#2F92EE;'>#ACE抑制剂#</a>, objectTitle=JASN：ACE抑制剂和ARB在肾功能受损者中的使用趋势, objectType=article, longId=167940, objectId=0fb416e9409f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fb416e9409f, replyNumber=0, likeNumber=36, createdTime=2019-06-11, rootId=0, userName=huanbaofeng, userId=fca217484051, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fb416e9409f, moduleTitle=JASN：ACE抑制剂和ARB在肾功能受损者中的使用趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fb416e9409f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587534, encodeId=8ce6158e53408, content=<a href='/topic/show?id=d1201843d5' target=_blank style='color:#2F92EE;'>#ACE抑制剂#</a>, objectTitle=肝脏安全问题促使强生公司放弃BACE抑制剂atabecestat的研发, objectType=article, longId=138664, objectId=50911386641a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50911386641a, replyNumber=0, likeNumber=24, createdTime=2018-05-22, rootId=0, userName=huanbaofeng, userId=fca217484051, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50911386641a, moduleTitle=肝脏安全问题促使强生公司放弃BACE抑制剂atabecestat的研发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50911386641a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587533, encodeId=ea1b158e533f7, content=<a href='/topic/show?id=d1201843d5' target=_blank style='color:#2F92EE;'>#ACE抑制剂#</a>, objectTitle=FDA授予礼来/阿斯利康阿尔茨海默氏症药物口服BACE抑制剂AZD3293快车道地位, objectType=article, longId=75773, objectId=b12ae57730c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b12ae57730c, replyNumber=0, likeNumber=36, createdTime=2016-08-25, rootId=0, userName=huanbaofeng, userId=fca217484051, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b12ae57730c, moduleTitle=FDA授予礼来/阿斯利康阿尔茨海默氏症药物口服BACE抑制剂AZD3293快车道地位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b12ae57730c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587532, encodeId=3741158e532fe, content=<a href='/topic/show?id=d1201843d5' target=_blank style='color:#2F92EE;'>#ACE抑制剂#</a>, objectTitle=BACE抑制剂——阿尔茨海默（AD）新药研发舞台中心的翩翩舞者, objectType=article, longId=75248, objectId=ebdae524873, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebdae524873, replyNumber=0, likeNumber=23, createdTime=2016-08-18, rootId=0, userName=huanbaofeng, userId=fca217484051, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebdae524873, moduleTitle=BACE抑制剂——阿尔茨海默（AD）新药研发舞台中心的翩翩舞者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebdae524873)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587531, encodeId=d2bd158e53147, content=<a href='/topic/show?id=d1201843d5' target=_blank style='color:#2F92EE;'>#ACE抑制剂#</a>, objectTitle=默沙东阿尔茨海默氏症BACE抑制剂MK-8931 Ib期临床取得积极数据, objectType=article, longId=21570, objectId=3ccb215e0b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ccb215e0b1, replyNumber=0, likeNumber=31, createdTime=2013-07-19, rootId=0, userName=huanbaofeng, userId=fca217484051, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ccb215e0b1, moduleTitle=默沙东阿尔茨海默氏症BACE抑制剂MK-8931 Ib期临床取得积极数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ccb215e0b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587530, encodeId=d1a9158e53045, content=<a href='/topic/show?id=d1201843d5' target=_blank style='color:#2F92EE;'>#ACE抑制剂#</a>, objectTitle=ACE抑制剂与β受体阻滞剂或许可预防化疗导致的心脏毒性, objectType=article, longId=17412, objectId=8f1e1e412de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f1e1e412de, replyNumber=0, likeNumber=35, createdTime=2013-04-17, rootId=0, userName=huanbaofeng, userId=fca217484051, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f1e1e412de, moduleTitle=ACE抑制剂与β受体阻滞剂或许可预防化疗导致的心脏毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f1e1e412de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1587529, encodeId=cf10158e5297a, content=<a href='/topic/show?id=d1201843d5' target=_blank style='color:#2F92EE;'>#ACE抑制剂#</a>, objectTitle=JAMA:ACE抑制剂可改善外周动脉疾病患者无痛行走和身体功能, objectType=article, longId=15156, objectId=8a331515673, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a331515673, replyNumber=0, likeNumber=33, createdTime=2013-02-08, rootId=0, userName=huanbaofeng, userId=fca217484051, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a331515673, moduleTitle=JAMA:ACE抑制剂可改善外周动脉疾病患者无痛行走和身体功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a331515673)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ACE抑制剂

2020-05-29

huanbaofeng (审核中...)

前往app查看评论内容

#ACE抑制剂#

Hypertension：伴有白蛋白尿的高血压成人中使用ACE抑制剂或ARB的趋势

2020-11-18

huanbaofeng (审核中...)

前往app查看评论内容

#ACE抑制剂#

ACE抑制剂和血管紧张素受体阻滞剂（ARBs）可能增加罹患COVID-19的风险

2020-03-26

huanbaofeng (审核中...)

前往app查看评论内容

#ACE抑制剂#

阿尔茨海默症治疗再遇挫折：Eisai和Biogen终止了BACE抑制剂elenbecestat的研发

2019-09-16

huanbaofeng (审核中...)

前往app查看评论内容

#ACE抑制剂#

又一个阿尔茨海默氏症的候选药宣布失败：安进、诺华放弃BACE抑制剂试验

2019-07-14

huanbaofeng (审核中...)

前往app查看评论内容

#ACE抑制剂#

JASN：ACE抑制剂和ARB在肾功能受损者中的使用趋势

2019-06-11

huanbaofeng (审核中...)

前往app查看评论内容

#ACE抑制剂#

肝脏安全问题促使强生公司放弃BACE抑制剂atabecestat的研发

2018-05-22

huanbaofeng (审核中...)

前往app查看评论内容

#ACE抑制剂#

FDA授予礼来/阿斯利康阿尔茨海默氏症药物口服BACE抑制剂AZD3293快车道地位

2016-08-25

huanbaofeng (审核中...)

前往app查看评论内容

#ACE抑制剂#

BACE抑制剂——阿尔茨海默（AD）新药研发舞台中心的翩翩舞者

2016-08-18

huanbaofeng (审核中...)

前往app查看评论内容

#ACE抑制剂#

默沙东阿尔茨海默氏症BACE抑制剂MK-8931 Ib期临床取得积极数据

2013-07-19

huanbaofeng (审核中...)

前往app查看评论内容

#ACE抑制剂#

ACE抑制剂与β受体阻滞剂或许可预防化疗导致的心脏毒性

2013-04-17

huanbaofeng (审核中...)

前往app查看评论内容

#ACE抑制剂#

JAMA:ACE抑制剂可改善外周动脉疾病患者无痛行走和身体功能

2013-02-08

科室
- - 订阅+
  - 更多科室
工具
服务